SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genitope GTOP
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche10/9/2007 9:39:18 AM
   of 37
 
9-Oct-2007

Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement.
On October 5, 2007, Genitope Corporation ("Genitope") entered into a common stock purchase agreement (the "Purchase Agreement") with William R. Hambrecht, Trustee of The Hambrecht 1980 Revocable Trust ("Hambrecht") relating to the registered direct offering, issuance and sale of 500,000 shares of Genitope's common stock (the "Shares"). Hambrecht has agreed to purchase the Shares from Genitope at a price of $4.05 per share. The offering is being made pursuant to Genitope's effective shelf registration statement on Form S-3 (Registration No. 333-128357) previously filed with the Securities and Exchange Commission.

(snip)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News